Hani Ashamalla

NewYork–Presbyterian Brooklyn Methodist Hospital

Also affiliated with Cornell University, Presbyterian Hospital

Physics and AstronomyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Characterization of TR ‐107, a novel chemical activator of the human mitochondrial protease ClpP”.

Characterization of TR ‐107, a novel chemical activator of the human mitochondrial protease ClpP

Pharmacology Research & Perspectives(2022)10.1002/prp2.993

N/A

0DataRank · unranked

43 citations

Lucas J. Aponte‐Collazo, Joshua D. Wynn, Kristina Drizyte‐Miller, Elisa Leung, Yoshimi Endo Greer +12 more

SMALL MOLECULE CLPP AGONISTS INDUCE SENESCENCE AND ALTER TRAIL-MEDIATED APOPTOTIC RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER CELLS

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.07.11.499620

N/A

0DataRank · unranked

3 citations

Emily M.J. Fennell, Michael P. East, Thomas S.K. Gilbert, Paul R. Graves, Hani Ashamalla +5 more

Characterization of TR-107, a Novel Chemical Activator of the Human Mitochondrial Protease ClpP

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.14.480426

N/A

0DataRank · unranked

1 citations

Lucas J. Aponte‐Collazo, Joshua D. Wynn, Kristina Drizyte‐Miller, Elisa Leung, Yoshimi Endo Greer +12 more

Small Molecule Activators of the Mitochondrial Protease ClpP Induce Senescence in Triple-Negative Breast Cancer Cells and Sensitize Cells to the Bcl-2 Inhibitor Venetoclax

Research Square(2025)10.21203/rs.3.rs-7682325/v1

N/A

0DataRank · unranked

0 citations

Sabrina Daglish, Owen G Canterbury, Paul R. Graves, Sarah Carter, Sydney Beese +18 more